Breast Milk Substitute Market is Set to Globally Reach US$ 59.3 Billion by 2035 at 9.4% CAGR | Fact.MR

The breast milk substitutes market will be USD 24.2 billion in 2025. The market will grow at a CAGR of 9.4% between 2025 and 2035 and reach USD 59.3 billion by 2035. This strong growth is led primarily by increasing awareness about infant nutrition, increase in the participation of females in the workforce, and improved access to formula-based substitutes across developed and emerging economies.

Breast milk substitutes are gaining popularity as nutritional science evolves, enabling the development of advanced formulas that closely mimic the composition and benefits of natural breast milk. Industry players are focusing on optimizing protein content, enhancing digestibility, and incorporating functional ingredients such as DHA, ARA, and probiotics. These innovations are building consumer confidence and broadening product appeal, especially among health-conscious and urban consumers.

For More Insights into the Market, Request a Sample of this Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=7652

Segment-wise Analysis

By Formula

Cow milk-based formulas are expected to lead the industry, with a 45% market share in 2025, followed by soybean-based formulas with an estimated 30% market share. These formulas provide for special nutritional requirements and likings, replicating the conflict between regional cuisines and medical issues.

By Form

In 2025, powdered formulas will keep on dominating the volume-based breast milk substitute market, holding 65% of the market, and liquid formulas will hold 35%. This product segmentation reflects the diverging tendencies of parents and caregivers towards convenience, prices, and shelf life.

Country-wise Analysis

The USA breast milk substitute market will advance at 5.6% CAGR during the forecast period. Growing awareness of the significance of infant nutrition and greater recognition of infant formula as a viable breast milk substitute are significant growth drivers of the industry. Growing numbers of working mothers and hectic lifestyles are equating to frequent demand for convenient and nutritionally dense formula options.

The UK breast milk substitute market will register 4.9% CAGR during the study period. Despite the promotion of breastfeeding, evolving parental taste and new parent-child relationships are contributing to higher usage of breast milk substitutes.

The German breast milk substitute market will register 4.3% CAGR during the study period. Growing demand for functional and organic nutrition is fueling the growth of breast milk substitutes. High baby health awareness, combined with high trust in pharmaceutical-quality nutritional products, positions Germany as a significant industry for the European continent. Country regulation is scientific-proof and purity-based, thereby extending the brand image and consumer confidence.

The South Korean market for breast milk substitutes is expected to rise at 5.2% CAGR during the study. Active parenting culture and a high-tech health system are fueling demand for high-quality breast milk substitutes. Urban lifestyles, delayed parenthood, and changes in family structures are bringing about increased use of infant formula, especially among dual-income households. Safety, nutritional sophistication, and convenience are extremely important to consumers.

The Chinese market for breast milk substitutes will increase at 6.3% CAGR during the research period. As the largest and most rapidly expanding breast milk substitute market, China is driven by factors such as rising birth rates, urbanization, and a shift towards premium infant foods.

Competitive Outlook

The market for breast milk substitutes is extremely concentrated and features top players like Abbott, Danone, Nestlé, and Reckitt (Enfamil), which have a dominant position in the market due to global brand value, research-backing formulations, and regulatory compliance.

Post-2024, Abbott will be concentrated largely on growing its ingredients for infant hypoallergenic and organically certified forms, addressing consumers' allergy worries and requirements on infant gut well-being. Danone keeps on investing in prebiotic and postbiotic technologies and personalizes its portfolio to address diverse nutritional requirements of consumers in Europe and Asia.

Nestlé has intensified its R&D activity on human milk oligosaccharides (HMOs) and eco-friendly packaging, targeting city consumers. Enfamil is kept competitively contemporary under Reckitt through hospital-grade offerings and open market accessibility in nascent industries. HiPP and Kendamil are projected as rising-star premium natural/organic brands, particularly across Europe, for palm oil-free and grass-fed milk-based alternatives.

Browse Full Report: https://www.factmr.com/report/breast-milk-substitute-market

Key Market Players

Abbott
Danone
Nestlé
Enfamil (Reckitt)
HiPP
Kendamil
Vitagermine SAS
Cow & Gate
Perrigo
Humana Inc.
Heinz
Fonterra

Segmentation

By Formula:
Cow Milk Protein
Soy-based Formula
Hydrolyzed Formula
Others (Goat Milk, Fruits & Vegetables)

By Form:
Powder
Liquid

By Consumer Age:
Below 6 Months
6-23 Months

By Distribution Channel:
Online
Brand Websites
E-commerce Platforms
Offline
Retail Stores
Pharmacies
Supermarkets/Hypermarkets

By Region:
North America
Latin America
Europe
East Asia
South Asia & Oceania
Middle East & Africa (MEA)

Check out More Related Studies Published by Fact.MR:

Jerky Snacks Market
https://www.factmr.com/report/jerky-snacks-market
Cognac Market
https://www.factmr.com/report/4051/cognac-market
Vitamin E Market
https://www.factmr.com/report/4606/vitamin-e-market
Lutein Market
https://www.factmr.com/report/1075/lutein-market

Contact:

US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232
Email: sales@factmr.com

About Fact.MR

We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.

This release was published on openPR.